These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9345463)
21. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS). Schorlemmer HU; Seiler FR Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035 [TBL] [Abstract][Full Text] [Related]
22. Altered expression of IGF-I system in neurons of the inflamed spinal cord during acute experimental autoimmune encephalomyelitis. Parvaneh Tafreshi A; Talebi F; Ghorbani S; Bernard C; Noorbakhsh F J Comp Neurol; 2017 Oct; 525(14):3072-3082. PubMed ID: 28617951 [TBL] [Abstract][Full Text] [Related]
23. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor. Hammer LA; Zagon IS; McLaughlin PJ Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432 [TBL] [Abstract][Full Text] [Related]
24. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. Stanislaus R; Singh AK; Singh I J Neurosci Res; 2001 Oct; 66(2):155-62. PubMed ID: 11592110 [TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis. Jiang H; Zhang F; Yang J; Han S Exp Neurol; 2014 Nov; 261():245-57. PubMed ID: 24852101 [TBL] [Abstract][Full Text] [Related]
26. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Roscoe WA; Welsh ME; Carter DE; Karlik SJ J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483 [TBL] [Abstract][Full Text] [Related]
27. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice. Zhu D; Liu M; Yang Y; Ma L; Jiang Y; Zhou L; Huang Q; Pi R; Chen X J Neurosci Res; 2014 Sep; 92(9):1217-26. PubMed ID: 24798871 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis. Li XB; Schluesener HJ Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257 [TBL] [Abstract][Full Text] [Related]
29. Gonadotropin-releasing hormone reduces the severity of experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Quintanar JL; Salinas E; Quintanar-Stephano A Neuropeptides; 2011 Feb; 45(1):43-8. PubMed ID: 21056467 [TBL] [Abstract][Full Text] [Related]
30. Pathological findings in rats with experimental allergic encephalomyelitis. Dong M; Liu R; Guo L; Li C; Tan G APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994 [TBL] [Abstract][Full Text] [Related]
37. Localization of toxic encephalopathies near lesions of experimental allergic encephalomyelitis. Levine S; Sowinski R Am J Pathol; 1982 May; 107(2):135-41. PubMed ID: 6979257 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of alprazolam on the development of acute experimental autoimmune encephalomyelitis in stressed rats. Núñez-Iglesias MJ; Novío S; Almeida-Dias A; Freire-Garabal M Pharmacol Biochem Behav; 2010 Dec; 97(2):350-6. PubMed ID: 20833196 [TBL] [Abstract][Full Text] [Related]
39. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis. Parvaneh Tafreshi A Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570 [TBL] [Abstract][Full Text] [Related]
40. Changes of extracellular space volume and tortuosity in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis. Simonová Z; Svoboda J; Orkand P; Bernard CC; Lassmann H; Syková E Physiol Res; 1996; 45(1):11-22. PubMed ID: 8884919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]